High-Risk Human Papillomavirus Is Associated with HIV Acquisition among South African Female Sex Workers

Background. Mounting evidence suggests an association between human papillomavirus (HPV) and HIV acquisition. This study aimed to explore this association among South African female sex workers (FSWs). Methods. We used data from 88 HIV-negative FSWs who participated in a vaginal gel (COL-1492) trial. Cervicovaginal rinse samples, obtained before HIV-seroconversion, were genotyped into high-risk (HR-) and low-risk (LR-) HPV. HIV-adjusted hazard ratios (aHRs) and 95% confidence intervals (CI) were estimated using Cox survival analysis. Results. HR- and LR-HPV prevalences were 70.5% (95% CI : 60.5–79.2) and 60.2% (95% CI : 49.9–70.0), respectively. Twenty-five women HIV seroconverted. Controlling for background characteristics and other sexually transmitted infections, HIV aHR increased by a factor of 1.7 (95% CI : 1.01–2.7, P linear trend = 0.045) for an increase of one unit of the number of HR-HPV genotypes. Conclusions. HIV seroconversion among FSWs is associated with genital HR-HPV infection. Further investigation is warranted, including testing the possible protective effect of available HPV vaccines on HIV acquisition.

[1]  J. H. van de Wijgert,et al.  HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda , 2010, AIDS.

[2]  Michael G Hudgens,et al.  Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. , 2010, The Journal of infectious diseases.

[3]  C. Morrison,et al.  The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe , 2010, AIDS.

[4]  A. van der Straten,et al.  Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections , 2010, PloS one.

[5]  A. Puren,et al.  Association of Oncogenic and Nononcogenic Human Papillomavirus With HIV Incidence , 2010, Journal of acquired immune deficiency syndromes.

[6]  Ross D. Cranston,et al.  Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men , 2009, AIDS.

[7]  E. Lagarde,et al.  Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. , 2009, The Journal of infectious diseases.

[8]  G. Ramjee,et al.  HIV‐1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV‐16 antibodies in female sex workers , 2009, Journal of medical virology.

[9]  H. Rees,et al.  Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions , 2008, AIDS.

[10]  S. Franceschi,et al.  Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda , 2008, International journal of cancer.

[11]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with human papillomavirus in females: a global review. , 2008, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[12]  X. Castellsagué.  Natural history and epidemiology of HPV infection and cervical cancer. , 2008, Gynecologic oncology.

[13]  Joakim Dillner,et al.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. , 2008, Vaccine.

[14]  A. Ouedraogo,et al.  Herpes simplex virus and HIV-1: deciphering viral synergy. , 2008, The Lancet. Infectious diseases.

[15]  T. Ngoma,et al.  Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening , 2008, BMC public health.

[16]  A. Williamson,et al.  Cervical and oral human papillomavirus types in HIV‐1 positive and negative women with cervical disease in South Africa , 2008, Journal of medical virology.

[17]  S. Gange,et al.  Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda , 2008, Cancer Epidemiology Biomarkers & Prevention.

[18]  T. Sasagawa,et al.  Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection , 2008, Journal of medical virology.

[19]  S. Gange,et al.  Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda , 2008, Sexually Transmitted Infections.

[20]  Richard G. White,et al.  Treating Curable Sexually Transmitted Infections to Prevent HIV in Africa: Still an Effective Control Strategy? , 2008, Journal of acquired immune deficiency syndromes.

[21]  S. Franceschi,et al.  Infection with human papillomavirus and HIV among young women in Kampala, Uganda. , 2008, The Journal of infectious diseases.

[22]  B. Monk,et al.  The spectrum and clinical sequelae of human papillomavirus infection. , 2007, Gynecologic oncology.

[23]  M. Steben,et al.  Human papillomavirus infection: epidemiology and pathophysiology. , 2007, Gynecologic oncology.

[24]  N. Kiviat,et al.  The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. , 2007, The Journal of infectious diseases.

[25]  P. Richards,et al.  The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa , 2007, BMC infectious diseases.

[26]  A. Puren,et al.  National HIV incidence measures--new insights into the South African epidemic. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[27]  G. Ramjee,et al.  The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. , 2006, Virus research.

[28]  H. Weiss,et al.  Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso , 2006, British Journal of Cancer.

[29]  N. Kiviat,et al.  Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. , 2006, Journal of the National Cancer Institute.

[30]  K. Anastos,et al.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. , 2005, Journal of the National Cancer Institute.

[31]  G. Nuovo,et al.  Distribution of Immune Cell Subsets and Cytokine-Producing Cells in the Uterine Cervix of Human Papillomavirus (HPV)-Infected Women: Influence of HIV-1 Coinfection , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[32]  E. Unger,et al.  Human Papillomavirus and Cervical Cancer , 2004, Emerging infectious diseases.

[33]  S. G. Gundersen,et al.  Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co‐infection on HPV genotype distribution , 2004, Journal of medical virology.

[34]  G. Dallabetta,et al.  Sexually Transmitted Infection Control with Sex Workers: Regular Screening and Presumptive Treatment Augment Efforts to Reduce Risk and Vulnerability , 2003, Reproductive health matters.

[35]  H. Rees,et al.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial , 2002, The Lancet.

[36]  B. Clarke,et al.  Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer , 2002, Molecular pathology : MP.

[37]  E. Gouws,et al.  HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour , 2001, AIDS.

[38]  P. Cristoforoni,et al.  Effects of Human Papillomavirus‐Associated Cells on Human Immunodeficiency Virus Gene Expression , 2000, Obstetrics and gynecology.

[39]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[40]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[41]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[42]  R. Newcombe.  Two-sided confidence intervals for the single proportion: comparison of seven methods. , 1998, Statistics in medicine.

[43]  D. Piron,et al.  Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. , 1998, Sexually transmitted infections.

[44]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[45]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[46]  M. Stanley,et al.  Immunological events in regressing genital warts. , 1994, American journal of clinical pathology.

[47]  M. Cobb.  Human Papillomavirus Infection-Core Concepts , 2019 .

[48]  K. Beutner.  Human papillomavirus infection. , 1989, Journal of the American Academy of Dermatology.